Clinical ResearchHeart Rhythm Disorder: Editorial CommentLenient Versus Strict Rate Control in Atrial Fibrillation: Some Devils in the Details⁎
Heart Rhythm Disorder: Editorial Comment
Under an Elsevier user license
open archive
Key Words
atrial fibrillation
atrial remodeling
rate control
Cited by (0)
Dr. Wyse has received honorarium from Boehringer Ingelheim, Medtronic, Bristol-Myers Squibb/Pfizer, sanofi-aventis, Biotronik, Merck, and Bayer.
- ⁎
Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.